跳到主要內容
:::

劉建廷

高雄長庚血液腫瘤科主治醫師

血液腫瘤科

乳癌、肺癌、大腸直腸癌

教職 : 助理教授

醫師網路掛號

※直接點選進入醫師網路掛號畫面※

語言

  • 國語,英語,閩南語

現職

  • 高雄長庚血液腫瘤科主治醫師

學歷

  • 長庚大學醫學系畢業

經歷

  • 高雄長庚血液腫瘤科主治醫師

學會與認證

  • 中華民國癌症醫學會
  • 台灣內科醫學會

論文及期刊發表

  • Sequential Assessments of the Eastern Cooperative Oncology Group Performance Scale Enhance Prognostic Value in Patients With Terminally Ill Cancer Receiving Palliative Care. American Journal of Hospice & Palliative Medicine, 2016; 33(5):471-6 (SCI ; IF=1.296 ; Health Care Sciences & Services 65/88)
  • Validation and Comparison of the 7th Edition of the American Joint Committee on Cancer Staging System and Other Prognostic Models to Predict Relapse-Free Survival in Asian Patients with Parotid Cancer. J Cancer. 2016 Aug 15;7(13):1833-1841. (SCI IF: 3.609 ONCOLOGY 73/213)
  • The efficacy and safety of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan. Asia-Pacific Journal of Clinical Oncology. 2016 doi: 10.1111/ajco.12571. (SCI IF: 1.722 ONCOLOGY 169/213)
  • Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan. J Cancer 2016; 7(7):854-861. doi:10.7150/jca.14777. (SCI IF: 3.609 ONCOLOGY 73/213)
  • Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow Metastases.Medicine.2015;94:e966 (SCI ; IF=2.133 MEDICINE,GENERAL&INTERNAL 40/153)
  • Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma. Onco Targets Therapy. 2015; 8: 1899–1907. (SCI ; IF=2.272 BIOTECHNOLOGY&APPLIED MICROBIOLOGY 70/161)
  • Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib. Medicine,2015;94:1-6 (SCI ; IF=2.133 MEDICINE,GENERAL&INTERNAL 40/153)
  • Multiple Endocrine Neoplasia Type 1 With Gastric Neuroendocrine Tumor Presented With Gastric Polyposis. Clinical Gastroenterology and Hepatology. 2015 May;13(5):e45 (SCI ; IF=7.680 ; GASTROENTEROLOGY & HEPATOLOGY 7/79)
  • Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma. The Scientific World Journal,2014;2014:160138 (NON SCI)
  • Necrolytic migratory erythema and glucagonoma rising from pancreatic cancer. Pancreatology. 2013 13(4), 455-457. (SCI IF: 2.043 GASTROENTEROLOGY & HEPATOLOGY 44/79)
  • Is there a role of whole-body bone scan in patients with esophageal squamous cell carcinoma.BMC Cancer, 2012 (12), 328. (SCI IF: 4.1 ONCOLOGY 85/213)
  • Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers. Experimental and Therapeutic Medicine. 2012;4:231-236 (SCI ; IF=1.280 MEDICINE, RESEARCH & EXPERIMENTAL 95/124)
  • Comparative study of esophageal stent and feeding gastrostomy/jejunostomy for tracheoesophageal fistula caused by esophageal squamous cell carcinoma. PLoS One, 2012;7:42766. (SCI IF: 4.092 Multidisciplinary Sciences 11/61)
  • Exendin-4 attenuates lipopolysaccharides induced inflammatory response but does not protect H9c2 cells from apoptosis. Immunopharmacol Immunotoxicol, 2012 June, 34(3), 484-90. (SCI IF: 1.829)
  • Trimodality Treatment for Locally Advanced, Resectable Esophageal Squamous Cell Carcinoma Journal of Cancer Research Practice, 2011;27:200-210 (NON SCI)
  • ,Metastatic Mucinous Colorectal Cancer: An Important Subtype of Colorectal Cancer with Poor Response to Chemotherapy and Overall Metastatic Mucinous Colorectal Cancer: An Important Subtype of Colorectal Cancer with Poor Response to Chemotherapy and Overall Survival Metastatic Mucinous Colorectal Cancer: An Important Subtype of Colorectal Cancer with Poor Response to Chemotherapy and Overall Survival. Journal of Cancer Research Practice,2010;26:221-230 (NON SCI)
  • Impact of comorbidity on survival for locally advanced head and neck cancer patients treated by radiotherapy or radiotherapy plus chemotherapy. Chang Gung Med Journal, 2010 May, 33(3), 283-91. (NON SCI)
長庚醫院智能服務 有任何問題隨時找我!